THIS COMPANY CANARIA RESORTS TO PLANTS ITS ARCHIPELAGO AS A SOURCE OF CHEMICALS.

Six years, Atlantic Center members Medicines, Ceamedsa, R & D company born as' spin off’ of the two Canarian universities, They are conducting research and development based on natural products from the area of ​​Macaronesia.

Elisa Pérez Sacau, PhD in Chemistry and director of this initiative, which also participates, private partner, the Canary Foundation Canario Cancer Institute, explains that in his years of activity, Ceamedsa has launched several lines of research that have resulted in commercial patents.

However, this entity has never had the ability to put these results in the market and ensure their effective marketing, which it caused much of the effort made not reach the public.

According to Perez Sacau, “This led us to request our participation in the Workshop on Assessment and Technology Commercialization. That was how he came to Ceamedsa Gabriela Borges, degree in organic chemistry from ULL and Valuation Management and Technology Commercialization.

Borges was responsible for analyzing patents were registered to give a candidate to be sold. After studying several possibilities, including an antitumor, the Statinib, which until now it was its star product, Both researchers opted to boost the launch of a worming with applications in animal husbandry and agriculture.

The compound in question has been removed from an endemic plant Canarian, the 'Ruta pinnata', which traditionally it has been used to eliminate intestinal parasites of goats, sheep and some young pet. This vermífugo also very effectively combat the pest thrips, of special emphasis on crops such as potatoes, tomato or flowers.

Perez said the achievement of reproducing this endemic culture laboratory, by techniques in vitro, so you can have the unlimited worming. according to comments, “now there is a great demand for biopesticides, due to the removal of chemicals market”.

Gabriela Borges insists precisely on this aspect. Aware of the difficulty of introducing an antitumor market, dominated by Big Pharma, He considers that the worming was presented as the best alternative: “It has been tested on larvae and worms with very positive results”.

Ceamedsa the next step will be the international marketing your product.